A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

NCT03485222 ·Status: COMPLETED ·Phase: PHASE4

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure

NCT03030222 ·Status: COMPLETED ·Phase: PHASE4

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

NCT01035255 ·Status: TERMINATED ·Phase: PHASE3

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

NCT03057951 ·Status: COMPLETED ·Phase: PHASE3

The Role of SGLT2i in Management of Moderate AS

NCT06469645 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®

NCT04570865 ·Status: UNKNOWN ·Phase: PHASE4

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

NCT00894868 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

NCT06307652 ·Status: RECRUITING ·Phase: PHASE3

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

NCT00799435 ·Status: TERMINATED ·Phase: PHASE4

Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus

NCT03753087 ·Status: COMPLETED ·Phase: PHASE4

Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction

NCT06619600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction

NCT03087773 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

NCT03552575 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

NCT02226120 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

NCT06597760 ·Status: COMPLETED ·Phase: PHASE1

Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction

NCT05420285 ·Status: UNKNOWN ·Phase: PHASE2

DDI Between BI Empagliflozin (10773) and Verapamil

NCT01276301 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

NCT03036124 ·Status: COMPLETED ·Phase: PHASE3

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

NCT04509674 ·Status: COMPLETED ·Phase: PHASE3

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone

NCT01807221 ·Status: COMPLETED ·Phase: PHASE2

Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

NCT06046612 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

NCT07038356 ·Status: RECRUITING ·Phase: PHASE3

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

NCT00187889 ·Status: COMPLETED ·Phase: PHASE4

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

NCT01067859 ·Status: TERMINATED ·Phase: PHASE2